Effectiveness and safety of osimertinib in patients with metastatic EGFR T790M-positive NSCLC: An observational real-world study. [electronic resource]
Producer: 20200303Description: e0221575 p. digitalISSN:- 1932-6203
- Acrylamides -- adverse effects
- Adult
- Aged
- Aged, 80 and over
- Aniline Compounds -- adverse effects
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- ErbB Receptors -- genetics
- Female
- Humans
- Kaplan-Meier Estimate
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Mutation -- genetics
- Neoplasm Metastasis
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.